Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04031963 · ClinicalTrials.gov registry record
Novel Biophotonics Methodology for Colon Cancer Screening
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 857
- Enrollment target
NCT04031963: Completed study, sponsored by Endeavor Health.
NCT04031963 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 857 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04031963 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 857 participants
- Enrollment target
Study Summary
This is a proposal to establish a Bioengineering Research Partnership (BRP). The major objective of the BRP is to refine and provide comprehensive, definitive multi-center validation of these novel methodologies for colorectal cancer (CRC) screening, thus providing a quantum leap in population screening.
Primary Outcome
ELF/LEBS probe used to obtain spectroscopy readings from rectal tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 857 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-05 |
What the finished NCT04031963 record still lists
NCT04031963 is an observational study that tracks outcomes without assigning an intervention. The registered 857 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04031963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04031963 about?
NCT04031963 is a clinical study titled "Novel Biophotonics Methodology for Colon Cancer Screening". This is a proposal to establish a Bioengineering Research Partnership (BRP). The major objective of the BRP is to refine and provide comprehensive, definitive multi-center validation of these novel methodologies for colorectal cancer (CRC) screening, thus providing a quantum leap in population scree...
What is the current status of trial NCT04031963?
This trial is currently completed. The enrollment target is 857 participants. The study started on 2009-09. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT04031963?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT05108896 · 855 participants · NA
Aspiration in Acute Respiratory Failure Survivors 2
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia